相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer
David M. Neskey et al.
CANCER RESEARCH (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Beyond BRAFV600: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma
Alan E. Siroy et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Gender Disparity and Mutation Burden in Metastatic Melanoma
Sameer Gupta et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Gender Disparity and Mutation Burden in Metastatic Melanoma
Sameer Gupta et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
HotSpotter: efficient visualization of driver mutations
Jason Roszik et al.
BMC GENOMICS (2014)
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53
Amaya Viros et al.
NATURE (2014)
Major Clinical Response to a BRAF Inhibitor in a Patient With a BRAF L597R-Mutated Melanoma
Philippe Bahadoran et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes
Rajesh R. Singh et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A. Jakob et al.
CANCER (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency
David S. Hong et al.
CLINICAL CANCER RESEARCH (2012)
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Gerald S. Falchook et al.
LANCET (2012)
BRAFL597 Mutations in Melanoma Are Associated with Sensitivity to MEK Inhibitors
Kimberly Brown Dahlman et al.
CANCER DISCOVERY (2012)
Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma
Julie A. Ellerhorst et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
Tamara Terzian et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
TP53 mutations in human cancers:: functional selection and impact on cancer prognosis and outcomes
A. Petitjean et al.
ONCOGENE (2007)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
分享论文
